SOLVONIS Trademark

Trademark Overview


On Friday, December 6, 2024, a trademark application was filed for SOLVONIS with the United States Patent and Trademark Office. The USPTO has given the SOLVONIS trademark a serial number of 79422293. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, December 11, 2025. This trademark is owned by Graft Polymer (UK) Plc. The SOLVONIS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Scientific laboratory services; clinical research services, namely, conducting clinical trials for others; scientific advisory, scientific analysis, assessment being quality control for others, assistance being technical support for others being testing and evaluation of clinical, laboratory and medical equipment and software to improve performance and efficiency of such equipment and software, and troubleshooting in the nature of diagnosing problems with clinical, laboratory and medical equipment and software, auditing being quality control for others, consultancy, design, development, due diligence being quality control for others, quality evaluation, scientific information, inspection being quality control for others, research and testing services in the fields of chemicals, of chemical substances, of biological substances, of biochemical substances, of science, of clinical research, of artificial intelligence, of machine learning and of biotechnology; scientific analysis, assessmen...

Pharmaceuticals and medical preparations being chemical intermediates, being chemical diagnostic preparations for medical purposes and being chemical preparations, small molecule pharmaceutical preparations and organic and synthetic pharmaceutical compounds for the treatment of neurodegenerative diseases, movement disorders, neurodevelopmental disorders, neurological disorders, conditions and diseases and of central nervous system disorders, conditions and diseases; pharmaceuticals and medical preparations being chemical preparations and small molecule pharmaceutical preparations and organic and synthetic pharmaceutical compounds for the treatment of behavioural health disorders, mental health disorders and addiction

Chemicals and chemical substances for use in industry, in science and chemical preparations for use in the manufacture of pharmaceuticals; biological and biochemical substances being organic chemical compounds, synthetic chemical compounds, enzymes, nucleic acids, non-medical chemical reagents, biochemical catalysts and non-medical diagnostic reagents for use in industry and science, peptide substrates for scientific purposes, proteins for use in manufacture, chemical solvents for use in the manufacture of pharmaceuticals, and small molecule chemical compounds and chemical intermediates for use in the manufacture of pharmaceuticals

Medical services; pharmaceutical compounding services; cognitive, behavioural, central nervous system, neurological, physical, psycho-social and mental health therapy services; cognitive, behavioural, central nervous system, neurological, physical, psycho-social and mental health telehealth services; mental health services; medical counselling services; psychological counselling services; psychotherapy services; health counselling services; behavioural health counselling services; health care services, namely design and provision of behavioural health treatment programmes; health care services, namely addiction counselling and treatment services; medical services, namely administration, advisory, analysis, assessment, assistance, consultancy, evaluation, information and testing services in the fields of cognitive, behavioural, central nervous system, neurological, physical, psycho-social and mental health therapy, of telehealth, of mental health, of medical counselling, of psychology, ...
solvonis

General Information


Serial Number79422293
Word MarkSOLVONIS
Filing DateFriday, December 6, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, December 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 30, 2025

Trademark Statements


Goods and ServicesScientific laboratory services; clinical research services, namely, conducting clinical trials for others; scientific advisory, scientific analysis, assessment being quality control for others, assistance being technical support for others being testing and evaluation of clinical, laboratory and medical equipment and software to improve performance and efficiency of such equipment and software, and troubleshooting in the nature of diagnosing problems with clinical, laboratory and medical equipment and software, auditing being quality control for others, consultancy, design, development, due diligence being quality control for others, quality evaluation, scientific information, inspection being quality control for others, research and testing services in the fields of chemicals, of chemical substances, of biological substances, of biochemical substances, of science, of clinical research, of artificial intelligence, of machine learning and of biotechnology; scientific analysis, assessment being quality control for others, assistance being technical support for others being testing and evaluation of clinical, laboratory and medical equipment and software to improve performance and efficiency of such equipment and software, and troubleshooting in the nature of diagnosing problems with clinical, laboratory and medical equipment and software, auditing being quality control for others, design, development, due diligence being quality control for others, quality evaluation, inspection being quality control for others, research and testing services in the fields of medicine, of pharmaceuticals, of medical diagnostics, of biomarkers and of bioinformatics; auditing being quality control for others, design, development, due diligence being quality control for others, inspection being quality control for others and research services in the fields of chemicals, chemical substances, biological substances, biochemical substances and pharmaceuticals for therapy, of telehealth, of mental health, of medical counselling, of psychology, of psychotherapy, of health counselling, of behavioural health counselling, of behavioural health, of behaviour and of addiction
Goods and ServicesPharmaceuticals and medical preparations being chemical intermediates, being chemical diagnostic preparations for medical purposes and being chemical preparations, small molecule pharmaceutical preparations and organic and synthetic pharmaceutical compounds for the treatment of neurodegenerative diseases, movement disorders, neurodevelopmental disorders, neurological disorders, conditions and diseases and of central nervous system disorders, conditions and diseases; pharmaceuticals and medical preparations being chemical preparations and small molecule pharmaceutical preparations and organic and synthetic pharmaceutical compounds for the treatment of behavioural health disorders, mental health disorders and addiction
Goods and ServicesChemicals and chemical substances for use in industry, in science and chemical preparations for use in the manufacture of pharmaceuticals; biological and biochemical substances being organic chemical compounds, synthetic chemical compounds, enzymes, nucleic acids, non-medical chemical reagents, biochemical catalysts and non-medical diagnostic reagents for use in industry and science, peptide substrates for scientific purposes, proteins for use in manufacture, chemical solvents for use in the manufacture of pharmaceuticals, and small molecule chemical compounds and chemical intermediates for use in the manufacture of pharmaceuticals
Goods and ServicesMedical services; pharmaceutical compounding services; cognitive, behavioural, central nervous system, neurological, physical, psycho-social and mental health therapy services; cognitive, behavioural, central nervous system, neurological, physical, psycho-social and mental health telehealth services; mental health services; medical counselling services; psychological counselling services; psychotherapy services; health counselling services; behavioural health counselling services; health care services, namely design and provision of behavioural health treatment programmes; health care services, namely addiction counselling and treatment services; medical services, namely administration, advisory, analysis, assessment, assistance, consultancy, evaluation, information and testing services in the fields of cognitive, behavioural, central nervous system, neurological, physical, psycho-social and mental health therapy, of telehealth, of mental health, of medical counselling, of psychology, of psychotherapy, of health counselling, of behavioural health counselling, of behavioural health, of behaviour and of addiction; medical advisory, consultancy and information services in the fields of medicine, of pharmaceuticals, of medical diagnostics, of biomarkers and of bioinformatics

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSolvonis Therapeutics plc
Party Type11 - New Owner Before Publication
Legal Entity Type84 - NOT AVAILABLE
AddressGB

Party NameGraft Polymer (UK) Plc
Party Type10 - Original Applicant
Legal Entity Type84 - NOT AVAILABLE
AddressGB

Trademark Events


Event DateEvent Description
Thursday, April 24, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 25, 2025APPLICATION FILING RECEIPT MAILED
Friday, May 16, 2025CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, May 27, 2025ASSIGNED TO EXAMINER
Monday, June 2, 2025NON-FINAL ACTION WRITTEN
Tuesday, June 3, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, July 26, 2025REFUSAL PROCESSED BY MPU
Saturday, July 26, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 16, 2025REFUSAL PROCESSED BY IB
Sunday, November 16, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, November 16, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, November 16, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 3, 2025EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 3, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, December 3, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 3, 2025EXAMINER'S AMENDMENT ENTERED
Friday, December 5, 2025APPROVED FOR PUB - PRINCIPAL REGISTER